FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372580007: Bronchodilator (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197874017 Bronchodilator (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211109010 Bronchodilator en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1197874017 Bronchodilator (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1197874017 Bronchodilator (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211109010 Bronchodilator en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1211109010 Bronchodilator en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
191731000077112 bronchodilatateur fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191731000077112 bronchodilatateur fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

82 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bronchodilator Is a Respiratory system agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Nitric oxide Is a True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol fumarate (substance) Is a False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ipratropium (substance) Is a True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Sympathomimetic agent (substance) Is a False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Respiratory smooth muscle relaxant Is a False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine and sodium benzoate injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by bronchodilator drug Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Accidental poisoning caused by bronchodilator drug Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Intentional poisoning caused by bronchodilator drug Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by bronchodilator drug of undetermined intent Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Bronchodilator preparations adverse reaction Causative agent (attribute) True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Bronchodilator preparations allergy Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Bronchodilator preparations overdose (disorder) Causative agent (attribute) True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Accidental bronchodilator preparations overdose Causative agent (attribute) True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Intentional bronchodilator preparations overdose Causative agent (attribute) True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Bronchodilator preparations overdose of undetermined intent Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Anticholinergic bronchodilators The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine bronchodilators The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Compound bronchodilators The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing xanthine (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Medicinal product acting as bronchodilator (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine 5mg/mL injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine citrate 20mg/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine citrate 20mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine + ergotamine tartrate 100mg/1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine + ergotamine tartrate 100mg/2mg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Acetaminophen+butalbital+caffeine 325mg/50mg/40mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Acetaminophen+butalbital+caffeine 500mg/50mg/40mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + caffeine + orphenadrine citrate tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Oral caffeine (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine in rectal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Oxitropium (substance) Is a True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Leukotriene receptor inhibitor (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing fluticasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms/blister disks+disk inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms/blister disks refill (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 25micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 125micrograms inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms/blister disks refill (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.5mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 2mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms CFC-free inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate topical preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 400micrograms single-use nasal drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.05% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Respiratory fluticasone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing fluticasone in nasal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing fluticasone in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Respiratory smooth muscle relaxant (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate [respiratory use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate[skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 600 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 250mg/2cc The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 160mg/15ml elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 50mg/1mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 400mg/10 mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 800 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 100mg/5mL oral liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 300 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 100mg/15mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 200mg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start